Clinical Trial Update: A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults [Phase 3]

View source ↗

Summary

Phase 3 open-label trial evaluating the efficacy and safety of sofosbuvir plus ribavirin in adults co-infected with chronic hepatitis C and HIV; the study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis C, Human Immunodeficiency Virus | Phase 3 | Status: COMPLETED | Results posted: 2015-04-30